Results 261 to 270 of about 941,634 (294)
Some of the next articles are maybe not open access.

Autoimmune hepatitis and pregnancy

Best Practice & Research Clinical Obstetrics & Gynaecology, 2020
Autoimmune hepatitis (AIH) is a rare liver disease of autoimmune aetiology that classically affects women at reproductive age. Diagnosis of AIH is not always straightforward, and other causes of chronic liver disease must be excluded. Pregnancy in patients with AIH is associated with an increased risk of adverse maternal and foetal outcomes.
A, Braga, C, Vasconcelos, J, Braga
openaire   +2 more sources

Acute Severe Autoimmune Hepatitis: Corticosteroids or Liver Transplantation?

Liver transplantation, 2019
Acute severe presentations of autoimmune hepatitis (AIH) represent a challenge for the transplant community. As a disease, it is poorly characterized, and there is a weak evidence base to guide diagnosis and treatment.
M. Rahim   +4 more
semanticscholar   +1 more source

Autoimmune Hepatitis in the Elderly

American Journal of Gastroenterology, 2001
Autoimmune hepatitis (AIH) is widely believed to be a disease of young women and menopause. Little is known about the frequency and clinical characteristics in patients aged > or =65 yr.We reviewed charts of 120 consecutive outpatients with known AIH to identify patients who were diagnosed at the age of 65 or older. These 20 patients (median age, 69 yr)
C, Schramm   +4 more
openaire   +2 more sources

Systematic review with meta‐analysis: mycophenolate mofetil as a second‐line therapy for autoimmune hepatitis

Alimentary Pharmacology and Therapeutics, 2019
First‐line treatment for autoimmune hepatitis (AIH) typically includes corticosteroids in combination with azathioprine. Mycophenolate mofetil (MMF) is often used as a rescue therapy in patients who are intolerant of, or nonresponsive to, standard ...
Priscila Santiago   +3 more
semanticscholar   +1 more source

Autoimmune hepatitis

The Indian Journal of Pediatrics, 1995
Autoimmune hepatitis can present as either acute or chronic disease in children. Clinical and laboratory features, including association with extrahepatic autoimmune syndromes and prompt response to immunosuppressive treatment, circulating autoantibodies and hypergammaglobulinemia, suggest an immune etiology.
openaire   +2 more sources

Attenuation of Experimental Autoimmune Hepatitis in Mice with Bone Mesenchymal Stem Cell-Derived Exosomes Carrying MicroRNA-223-3p

Molecules and Cells, 2019
MicroRNA-223-3p (miR-223-3p) is one of the potential microRNAs that have been shown to alleviate inflammatory responses in pre-clinical investigations and is highly encased in exosomes derived from bone mesenchymal stem cells (MSC-exosomes). MSC-exosomes
Feng-Bin Lu   +12 more
semanticscholar   +1 more source

Incidence, prevalence, and causes of death of patients with autoimmune hepatitis: A nationwide register-based cohort study in Finland.

Digestive and Liver Disease, 2019
BACKGROUND Epidemiological studies of autoimmune hepatitis are scarce and often based on single centre registries. AIMS We conducted a nationwide register study of incidence, prevalence, survival, and causes of death of autoimmune hepatitis patients in
L. Puustinen   +3 more
semanticscholar   +1 more source

Pathogenesis of autoimmune hepatitis

Clinics in Liver Disease, 2002
Autoimmune hepatitis is initiated by CD4 T cells that recognize self-antigen. The effector cells differentiate into functional phenotypes according to cytokines in the microenvironment and the nature of the triggering antigen. Hepatocytes can express class II molecules and present antigenic peptides through a bystander mechanism.
Vergani, D   +3 more
openaire   +2 more sources

The Geoepidemiology of Autoimmune Hepatitis

Clinical Reviews in Allergy & Immunology
Autoimmune hepatitis (AIH) is typically a chronic, inflammatory, and progressive liver disease of autoimmune origin. Currently, two recognized types are identified in clinical practice: type 1 and type 2. The disease can occur in all geographic regions and racial/ethnic groups worldwide, but shows marked variations.
Yang, Li   +5 more
openaire   +2 more sources

Transplantation for Autoimmune Hepatitis

Seminars in Liver Disease, 2002
Autoimmune hepatitis (AIH) is a good indication for liver transplantation, with 5- and 10-year survival rates approaching 75%. Determining the timing for transplantation remains difficult because progression to end-stage disease may be difficult to predict. After transplantation, the patients are at risk of recurrent AIH.
openaire   +2 more sources

Home - About - Disclaimer - Privacy